Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
作者信息
Gardner Roy S, McGowan James, McDonagh Theresa A
机构信息
The Scottish Cardiopulmonary Transplant Unit, Royal Infirmary, Glasgow, UK.
出版信息
Eur J Heart Fail. 2002 Jun;4(3):377-9. doi: 10.1016/s1388-9842(02)00012-0.
Abstract
A 49-year-old cardiac transplant recipient with idiopathic left ventricular systolic dysfunction was treated with carvedilol. After 8 months, his ejection fraction, measured by radionuclide ventriculography, had increased from 14 to 30% with an associated improvement in symptoms.
摘要
相似文献
1
Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
Eur J Heart Fail. 2002 Jun;4(3):377-9. doi: 10.1016/s1388-9842(02)00012-0.
2
Carvedilol in the failing heart.
Clin Cardiol. 2001 Dec;24(12):757-66. doi: 10.1002/clc.4960241202.
3
Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Am Heart J. 2000 Apr;139(4):596-608. doi: 10.1016/s0002-8703(00)90036-x.
4
5
Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.
Eur J Heart Fail. 2002 Jun;4(3):269-76. doi: 10.1016/s1388-9842(01)00239-2.
6
Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment.
J Am Coll Cardiol. 2002 Dec 4;40(11):2034-8. doi: 10.1016/s0735-1097(02)02570-6.
7
Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.
Transplant Proc. 2002 Feb;34(1):177-8. doi: 10.1016/s0041-1345(01)02717-8.
8
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.
Lancet. 2003 Jul 5;362(9377):14-21. doi: 10.1016/s0140-6736(03)13801-9.
9
The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure.
Int J Cardiol. 2000 Feb 15;72(3):265-74. doi: 10.1016/s0167-5273(99)00198-9.
10
Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Int J Cardiol. 2006 Feb 15;107(2):220-4. doi: 10.1016/j.ijcard.2005.03.028.
引用本文的文献
1
Should we consider heart rate reduction in cardiac transplant recipients?
Clin Cardiol. 2013 Feb;36(2):68-73. doi: 10.1002/clc.22048. Epub 2012 Aug 21.
Zotero 插件